tmem120a Antibody

What is TMEM120A and why is it significant for antibody-based research?

TMEM120A is a membrane protein highly conserved in vertebrates that was initially identified as a nuclear envelope transmembrane protein (NET29). Recent structural and functional studies have revealed its complex nature and potential dual roles. TMEM120A forms a tightly packed dimer with extensive interactions mediated by the N-terminal coiled coil domain (CCD), the C-terminal transmembrane domain (TMD), and the re-entrant loop between these domains . While initially proposed to be a mechanosensitive channel involved in sensing mechanical pain (also known as ion channel TACAN), newer structural evidence suggests it may function as an enzyme for fatty acid metabolism . This protein contains six transmembrane helices forming an α-barrel with a deep pocket where a coenzyme A (CoA) molecule binds . Its expression in adipose tissue, nociceptors, and its role in adipocyte differentiation make it a significant target for researchers studying these biological processes . Antibodies against TMEM120A are essential tools for investigating its localization, function, and interactions in these diverse contexts.

What applications are TMEM120A antibodies typically used for?

TMEM120A antibodies are validated for several key applications in molecular and cellular biology research. The commonly supported applications include:

• Western blot (WB) analysis with recommended dilutions around 1:300

• Enzyme-linked immunosorbent assay (ELISA)

• Immunohistochemistry (IHC) with recommended dilutions around 1:50

These antibodies serve as valuable tools for detecting TMEM120A expression levels, studying its subcellular localization (reported in both nucleus and cell membrane), and investigating its roles in adipocyte differentiation and mechanosensation . The specific dilutions and protocols may vary between antibody products and should be optimized for individual experimental conditions.

What species reactivity do commercial TMEM120A antibodies typically demonstrate?

Commercial TMEM120A antibodies show varying species reactivity profiles. Based on the reviewed products, many antibodies demonstrate cross-reactivity across multiple mammalian species. For instance:

• The rabbit polyclonal antibody from Proteintech (catalog #17455-1-AP) recognizes human, mouse, and rat TMEM120A antigens

• The mouse-produced antibody from Sigma-Aldrich (catalog #SAB1409874) is specifically reactive to human TMEM120A

When selecting a TMEM120A antibody for your research, it's crucial to verify the species reactivity to ensure compatibility with your experimental model. This information is typically provided in the product specifications or can be found by consulting the antibody manufacturer's technical documentation .

How can researchers validate the specificity of TMEM120A antibodies?

Validating antibody specificity is critical for reliable TMEM120A research. A comprehensive validation approach should include:

• Genetic controls: Utilize TMEM120A knockout or knockdown systems to confirm antibody specificity. The literature indicates that Sigma MISSION clones such as TRCN0000247877 targeting the CDS of TMEM120A can be used to generate knockdown models . Compare antibody staining or blotting between wild-type and knockdown/knockout samples to verify specific binding.

• Recombinant expression validation: Overexpress tagged versions of TMEM120A (such as GFP-tagged variants) to confirm co-localization or detection with the antibody. The mouse and human TMEM120A coding sequences can be PCR amplified and cloned into vectors like pEGFP-N2 as described in the literature .

• Cross-reactivity assessment: Test for cross-reactivity with TMEM120B, a closely related family member. Due to potential sequence similarities, antibodies may detect both proteins. Differential expression patterns or molecular weights (if known) can help distinguish between them.

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide before application to verify that specific binding is blocked.

• Multiple antibody comparison: When possible, use multiple antibodies targeting different epitopes of TMEM120A to confirm consistent results across detection methods.

What are the optimal conditions for using TMEM120A antibodies in Western blot analysis?

Optimizing Western blot protocols for TMEM120A detection requires attention to several key factors:

• Sample preparation: Given TMEM120A's membrane localization, effective membrane protein extraction is crucial. The literature describes successful extraction using detergents such as lauryl maltose neopentyl glycol (LMNG) or digitonin . For TMEM120A protein studies, sample homogenization by sonication followed by extraction with 1% (w/v) LMNG has been successfully employed .

• Antibody concentration: Starting dilutions typically range from 1:300 to 1:1000, but optimization is recommended for each specific antibody and experimental setup.

• Molecular weight considerations: The canonical human TMEM120A has a molecular weight of approximately 40.6 kDa . When interpreting bands, consider that post-translational modifications or differential splicing may affect migration patterns.

• Blocking conditions: For polyclonal antibodies, 5% non-fat dry milk in TBST is often effective, but BSA-based blocking may be preferred for phospho-specific detection if applicable.

• Detection system selection: For low abundance targets, consider enhanced chemiluminescence (ECL) systems or fluorescence-based detection for improved sensitivity and quantification.

• Controls: Include positive controls (tissues known to express TMEM120A, such as adipose tissue) and negative controls (tissues with minimal expression or knockdown samples).

How can researchers distinguish between TMEM120A and TMEM120B using antibodies?

Distinguishing between these closely related family members requires careful antibody selection and experimental design:

• Epitope selection: Choose antibodies raised against regions with minimal sequence homology between TMEM120A and TMEM120B. The C-terminal regions often show greater divergence and may provide better discrimination.

• Validation with recombinant proteins: Express recombinant TMEM120A and TMEM120B separately and test the antibody against both to assess cross-reactivity. The literature describes cloning methods for both genes from mouse 3T3-L1 cDNA libraries using specific primers .

• Isoform-specific knockdowns: Use targeted knockdown of each isoform separately to confirm antibody specificity. For example, MISSION clones targeting the CDS of TMEM120A have been described in the literature .

• Co-immunolabeling: When possible, use differentially labeled antibodies against both proteins to assess co-localization or distinct distribution patterns.

• Expression pattern analysis: Consider the known differential expression patterns of these two proteins across tissues and cell types to help interpret results.

How can TMEM120A antibodies be used to study its role in mechanosensation versus fatty acid metabolism?

This question addresses the emerging debate about TMEM120A's primary function. Recent structural studies suggest it may function as an enzyme in fatty acid metabolism rather than a mechanosensitive channel . Researchers can use antibodies to investigate this dual functionality through:

• Subcellular localization studies: Use immunofluorescence with TMEM120A antibodies to examine its distribution in different cell types. Co-localization with known markers of mechanosensitive structures versus metabolic compartments can provide functional insights.

• Protein-protein interaction studies: Employ co-immunoprecipitation with TMEM120A antibodies to identify binding partners associated with either mechanosensation or fatty acid metabolism pathways.

• Context-dependent expression analysis: Compare TMEM120A expression (via Western blot) in tissues primarily associated with mechanosensation (e.g., nociceptors) versus those dominant in fatty acid metabolism (e.g., adipose tissue).

• Functional state detection: Develop or identify antibodies that can distinguish between different conformational or binding states of TMEM120A, particularly those related to CoA binding.

• Correlation studies: Combine antibody-based detection of TMEM120A with functional assays for mechanosensation and fatty acid metabolism to correlate expression levels with specific functions across different cellular contexts.

What methodologies can researchers employ to study TMEM120A's interaction with coenzyme A using antibodies?

The discovery that TMEM120A binds coenzyme A (CoA) opens important research directions . Antibody-based approaches to study this interaction include:

• Proximity ligation assays (PLA): Combine TMEM120A antibodies with CoA-binding antibodies or labeled CoA to visualize and quantify interactions in situ.

• Conformation-specific antibodies: Develop or identify antibodies that specifically recognize the CoA-bound versus unbound states of TMEM120A.

• Co-immunoprecipitation coupled with metabolite analysis: Use TMEM120A antibodies for immunoprecipitation followed by mass spectrometry analysis to detect bound CoA or related metabolites. Previous research has successfully identified CoA bound to TMEM120A using LC-MS/MS after protein precipitation with methanol .

• Competition assays: Design experiments where free CoA or CoA analogs compete with antibody binding if the epitope overlaps with the CoA binding site.

• Structural analysis with antibody fragments: Use Fab fragments of TMEM120A antibodies in co-crystallization or cryo-EM studies to stabilize specific conformations relevant to CoA binding.

• Mutational analysis combined with antibody detection: Create mutations in the CoA binding pocket of TMEM120A and use antibodies to assess how these mutations affect protein expression, localization, and function.

What controls should be included when using TMEM120A antibodies in experimental procedures?

Proper controls are essential for reliable interpretation of results with TMEM120A antibodies:

• Positive tissue controls: Include samples from tissues known to express TMEM120A, such as adipose tissue or nociceptors .

• Negative controls:

  • Primary antibody omission

  • Isotype controls matching the TMEM120A antibody's host species and isotype (typically IgG for polyclonal rabbit antibodies)

  • Tissues or cells with confirmed low/no TMEM120A expression

  • TMEM120A knockdown samples

• Specificity controls:

  • Peptide competition/blocking with the immunizing antigen

  • Comparison of staining patterns using multiple antibodies targeting different TMEM120A epitopes

• Technical controls:

  • For Western blots: loading controls and molecular weight markers

  • For IHC/ICC: autofluorescence controls and counter-staining

• Functional validation: When possible, correlate antibody detection with functional assays related to TMEM120A's proposed roles in mechanosensation or fatty acid metabolism.

How should researchers optimize storage and handling of TMEM120A antibodies to maintain performance?

Proper storage and handling are critical for maintaining antibody performance:

• Storage conditions: Most TMEM120A antibodies should be stored at -20°C, as indicated in product information . Some antibodies are supplied in buffers containing glycerol (e.g., PBS with 0.02% sodium azide and 50% glycerol, pH 7.3) to prevent freeze-thaw damage.

• Aliquoting: Upon receipt, divide antibodies into small single-use aliquots to minimize freeze-thaw cycles, which can degrade antibody performance.

• Thawing protocol: Thaw antibodies on ice or at 4°C rather than at room temperature to preserve activity.

• Working dilutions: Prepare working dilutions fresh on the day of the experiment whenever possible. If storage is necessary, keep diluted antibodies at 4°C for short periods (1-2 weeks maximum).

• Contamination prevention: Use sterile technique when handling antibodies to prevent microbial contamination.

• Transportation: When transporting between facilities, maintain the cold chain using dry ice for frozen antibodies .